site barate
(aretic)
87/100
SUPPIE SCORE
68/100
EFFICACY
High
SAFETY
100/100
CLEANLINESS
What Does (aretic) Do?
250 mg NMN (CellVive NMN™) aligns with the lower end of studied doses showing NAD+ increases and modest physical performance signals; 70 mg choline from bitartrate is a modest contribution relative to typical intakes and adequate-intake references.
What evidence supports 250 mg NMN daily for NAD+ levels?
How does 70 mg choline from bitartrate compare to typical needs?
Are there any specific cautions for combining NMN and choline?
Chat with Suppie
What Are the Benefits of (aretic)?
Based on proven scientific research
NAD+ supportStrong
Physical performanceModerate
Metabolic markersMild
Good For:
What Are the Side Effects of site barate (aretic)?
Always consult your health practitioner if in doubt.
RiskLow Risk
Overview
•NMN doses up to 2000 mg/day showed no increase in adverse events in short-term trials.
•Choline bitartrate at this amount contributes 70 mg choline, well below the 3.5 g/day upper limit.
•Evidence limited on long-term NMN use beyond 24 weeks.
•Choline bitartrate may raise TMAO levels more than phospholipid sources.
Potential Side Effects
Negative Interactions
Inactive Ingredients
Safe Formulation!
Great news, this product doesn't contain harmful ingredients!
What Are the Ingredients in site barate (aretic)?
Nicotinamide mononucleotide (CellVive NMN™)
250 mg
Choline bitartrate
17544 mg
equiv. Choline
70 mg
Scan the bottle in your cupboard
Same graded report you just read — on any label, in about 10 seconds.
Dosage & Bioavailability
How the active doses and forms in (aretic) compare to the research.
•Nicotinamide mononucleotide (CellVive NMN™) — 250 mg; studied doses range 250-2000 mg/day with NAD+ increases observed at 250 mg and higher in trials up to 12 weeks.
•Choline bitartrate — 17544 mg (equiv. 70 mg choline); choline bitartrate provides approximately 41% choline by weight and absorption is lower than from phospholipid sources per.
•Nicotinamide mononucleotide (CellVive NMN™) — 250 mg; trials used ordinary free NMN or microcrystalline forms with no clear form-specific bioavailability advantage demonstrated.
Frequently Asked Questions
Common questions about site barate (aretic)